by Frances Martel, Breitbart:
World Health Organization (W.H.O.) Director-General Tedros Adhanom Ghebreyesus announced on Wednesday that trials for two potential therapeutics to fight the Ebola Bundibugyo virus would begin next week.
Ebola Bundibugyo is the strain of the virus currently fueling an ongoing outbreak in the Democratic Republic of the Congo (DRC) and Uganda, found to have infected over a thousand people since May and most recently identified in a returning health worker in France. Bundibugyo is a less common strain than those that fueled previous outbreaks in the DRC and Guinea, such as the Zaire and Sudan strains of the virus. Currently, no approved vaccine, therapeutic, or other medical protocol exists to treat a Bundibugyo infection.
TRUTH LIVES on at https://sgtreport.tv/
That situation may end soon if the trials beginning in DRC yield positive results. According to Tedros, Ebola patients will receive doses of two antiviral products, MBP134 and Remdesivir, to monitor whether they can facilitate a faster recovery or not.
“Preparations are now complete for a trial of two therapeutics that are expected to start in DRC in the next week,” Tedros told reporters during a briefing on Wednesday. “The trial will evaluate whether 2 antivirals, MBP134 and Remdesivir, can help to reduce mortality in patients with Bundibugyo alone or in combination.”
